Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by mercedesmanon Sep 16, 2022 10:38am
318 Views
Post# 34966796

Will there be ....

Will there be .......a surprise/innovative/large partner-participating injection that either unveils the true value of PMX, or that uncovers the hidden value of Dialco, which in-turn causes the stock to almost instantly re-rate higher ?...


or...

...will there be be one last grab, before the final assault on two more HIGHLY valuable FDA approvals to go with the 2.5 they already have now  (EAA, SAMI , and DIMI for medically supervised use)...

Reminder on the last two FDA - related pieces of the puzzle (really 1.5):

One is described as "a when not if event" and the other will be determined by a "Confirmatory Trial" that is "exceeding expectations", wherein enrolment is set to accelerate appreciably (due to fall flu season and increase Sepsis incidences, protocol changes, increased number of trial sites, etc.)


tic..toc..tic..toc

MM
<< Previous
Bullboard Posts
Next >>